The Morning Hammer: Something’s Gotta Give!
Don’t Fear Forex… Attend my buddy Kurt Capra free webinar tonight and learn why so many stock and options traders are embracing the lucrative world of forex. Click here for more info. European markets are up this morning on solid economic data. Euro area PMI rose to 53.3 in August from 53.3, which implies little impact from the Brexit. France’s was better than expected, while Germany’s was a little weaker. On the US economic calendar, we’ve got the Markit US manufacturing PMI, Richmond Fed, and New Home Sales. Best Buy (BBY) beat by a mile and is up 14%, extending what’s generally been a pretty decent earnings season for big box retailers. Meanwhile, the Bank of Montreal (BOM) beat on strong retail banking activity. SPX futures are in modestly positive territory following yesterday’s yawnfest. Biotech is indicated higher following massive outperformance on the back of the Pfizer (PFE)/Medivation (MDVN) deal. Bloomberg is reporting that Bayer and Monsanto (MON) are closer to closing their deal, which has been stuck on issues like the price and termination fee. Crude oil is down again this morning after Iraq’s Oil Minister asked foreign oil companies to increase oil production and exports. The dollar is down after making solid gains on hawkish comments from the Fed’s Fischer and other officials. Some traders may be taking their feet off the gas ahead of FOMC Chair Janet Yellen’s Jackson Hole speech this Friday. I’m not in the business of trying to game the Fed, so I’ll just point out that in June, Yellen came out dovish after a barrage of hawkish comments from Fed officials. So please, tread carefully. Otherwise, we’re back to the same old grind. The action’s been so lame that it makes the April-May lull look like a firestorm in comparison. I am long VIX calls and I’m sitting on a loss of about 8%. That’s not the end of the world, but now I’m in that no man’s land where I’m worried about getting shaken out at the worst possible moment. But I’m going to stick it out for now. Arguing with the market is for fools, but we’ve gone 31 days without a 1% move. And we’ve gone 39 days without a 1% down move. Something’s gotta give. Right? P.S. Don’t forget to sign up for Kurt Capra’s free forex trading event!
Continue Reading -->T3’s Take 3: Biotech Booms Amid Epic Snoozefest!
Get Started in Forex! My buddy Kurt Capra is hosting a FREE introductory webinar on forex trading tomorrow after the close. Click here to check it out. You can also read this article if you’d like to get to know Kurt a little better. 1) Biotech Booms! It was an altogether lackluster day for the major averages, but biotech put in a booming performance that had the NASDAQ Biotech Index ETF (IBB) up a whopping 2.0%. Traders were pumped up by Pfizer’s (PFE) $14 billion acquisition of cancer drug maker Medivation (MDVN), which could set off even more deal activity. Reuters had reported that several other players, including Gilead (GILD) and Merck (MRK) considered buying Medivation, so presumably, these suitors will seek other targets now that Pfizer has sealed the deal here. 2) Yawn! At the open this morning, the S&P 500 dipped and the VIX spiked, which had many market observers (including myself) hoping that we’d finally see some real downside volatility. It wasn’t to be. The hot action in biotech kept the bears at bay, and the Russell 2000 put in a pretty decent performance as well. Crude oil took a big hit today as traders are becoming less certain that OPEC will freeze or cut production at the big meeting in December. The S&P finished down -0.1% at 2183, making today the 31st day without a 1% move in the index. 3) Hawks Fly? On Sunday, Fed vice-chairman Stanley Fischer said the US economy was closing to hitting full employment and the Fed’s 2% inflation goal. Right now, traders are pricing in a 51% chance of a December rate hike, so markets are split right down the middle. We may get some clarity with FOMC Chair Janet Yellen’s speech at Jackson Hole on Friday. But I’d like to caution traders against making a rush to judgement on what Yellen may say. Don’t forget that many Fed officials came out hawkish ahead of the June meeting, only to be shocked by a dovish statement. P.S. Don’t forget to check out Kurt’s FREE forex webinar! Tuesday’s Trading Calendar US Economics (Time Zone: EDT) 10:00 New Home Sales (Jul): exp. 580k, prior 592k 10:00 Richmond Fed Manufacturing Index (Aug): prior 10 Global Economics 12:00 JPY BOJ Gov Kuroda Speaks 03:00 EUR French Flash Manufacturing PMI 03:30 EUR German Flash Manufacturing PMI 04:00 EUR Flash Manufacturing PMI 18:45 NZD Trade Balance 21:30 AUD Contruction Work Done q/q Earnings Before Open: Best Buy Co (BBY) Toll Brothers (TOL) After Close: Intuit Inc (INTU) Lannett Company (LCI)
Continue Reading -->Biotech powers up! And 4 other thoughts on today’s action…
1) BIo-Defense Biotech (IBB) put up a nice defense against that first little dip that started at 9:45 a.m. ET, and IBB is up 1.5% on the day — good stuff! The rest of the market was looking a little shaky, but traders tend to feel good when biotech is going strong. I’m positioned bearish near-term so I want biotech to get hit hard, but I’m not holding my breath just yet. 2) OPEC Reality? It seems like traders are finally remembering the disappointment at the June OPEC meeting meeting, when many people were expecting a production freeze. Crude oil is down -2.8% and oil service names are feeling the ugly stick. Let’s see if the rest of the market starts to notice. 3) HYG HYG has been quite strong as of late courtesy of the oil rebound. (crude oil prices and high-yield energy bond prices are closely tied for obvious reason). I’d closely track it, particularly its relative performance against Treasury ETFs like IEF. Bad high-yield makes equity markets nervous. 4) Declining Earnings — Who Cares? The permabears are out chattering about the fact that we’re on a 5-quarter streak for negative earnings — something we haven’t seen since the 2008-2009 crisis. Does it matter? Sure! But you know what matters even more? The fact that while bad, earnings are not quite as awful as expected. I’m choosing not to care about this until Mr. Market tells me it’s important via price action. 5) And the Swoon…. As I’m writing this, SPX has come off morning highs by a few points and approaching the morning low of 2175.96. It’s been a long, long time since we’ve seen a hard intraday reversal that turned into a meaningful down day. Will we get it today? Biotech and oil have the answer, so watch em!
Continue Reading -->The Morning Hammer: The Broken Record Market
Don’t Fear Forex… Attend my buddy Kurt Capra free webinar tomorrow and learn why so many stock and options traders are embracing the lucrative world of forex. Click here for more info. SPX futures are taking a small hit today as oil pulls back and the dollar keeps rising on Fed rate hike speculation. Morgan Stanley and Barclays both issues notes stating that crude prices would correct. There is also growing doubt that OPEC will institute a production freeze or cut at its September meeting. As I pointed out last week, oil ran up big into the June OPEC meeting on speculation of an output freeze. OPEC did nothing, and oil topped out shortly thereafter. It seems like folks are finally starting to remember that. On Sunday, Fed vice-chairman Stanley Fischer said the US economy was closing to hitting full employment and the Fed’s 2% inflation goal. Right now, traders are pricing in a 51% chance of a December rate hike, so markets are split right down the middle. We may get some clarity with FOMC Chair Janet Yellen’s speech at Jackson Hole on Friday. But I’d like to put an emphasis on the word MAY. Don’t forget that many Fed Heads came out hawkish ahead of the June meeting, only to be surprised by a dovish statement. The US economic calendar is pretty light — we just have the Chicago Fed National Activity Index hitting at 8:30 a.m. ET. At 12:00 p.m., German Chancellor Angela Merkel, French President Francois Hollande, and Italian Prime Minister Matteo Renzi will hold a press conference on the state of the European Union. On the deal front, Pfizer (PFE) is buying cancer drug maker Medivation (MDVN) for $14 billion. Reuters reported that several other players including Gilead (GILD) and Merck (MRK) were interested in Medivation. And a US security panel approved ChemChina’s $43 billion takeover of pesticide/seed giant Syngenta (SYT). The VIX is up 13%, which implies some more tension on the tape, but the bears still need to deliver some real downside follow-through to provide a real scare. We’ve gone 30 trading days without a 1% move in the SPX. I’ve got my fingers crossed that we’re finally passing this stretch of boredom, but I’m not holding my breath. P.S. Don’t forget to sign up for Kurt Capra’s free forex trading event!
Continue Reading -->Morning Call Express: Don’t Fall Asleep At The Wheel
Don’t Fear Forex… Attend my buddy Kurt Capra free webinar tomorrow and learn why so many stock and options traders are embracing the lucrative world of forex. In today’s Morning Call Express, Soctt Redler talks about the current trend of the SPX and the key levels to be watching for technical support. He also looks at various sectors like the Nasdaq Biotech. (IBB) as well as key, high beta tech names like AMZN, FB, and others. Scott also notes that banks and gold could be key sectors to watch going into this week.
Continue Reading -->T3’s Take 3: 30 Days of Nothing…
Don’t Fear Forex… Are you a stock or options trader in search of new profit opportunities? Click here to attend a FREE forex trading webinar 1) 30-Day Grind Today was the 30th straight day that the S&P 500 index failed to make a 1% move. Year-to-date ahead of this stretch the S&P moved 1% about once every 3 days, so I’m not exaggerating when I say this is the most boring market I’ve ever seen. The index finished down -0.2% at 2184, while the Russell 2000 and Nasdaq Composite did slightly better. Deere (DE) and Foot Locker (FL) both rose sharply on their strong earnings reports, while biotech and oil service names fell. 2) Fed Follies! On Wednesday, the Fed released the dovish-leaning Minutes from its July meeting. But on Thursday, Fed officials Williams and Dudley both said rate hikes are on the table in the near-term, which has traders ratcheting up their rate hike expectations once again. That sent bond and gold lower today, while regional banks (which benefit from higher rates) caught a small bid. Next week, Fed Chair Janet Yellen will speak at an annual meeting of central bankers in Jackson Hole, Wyoming, and will likely give some more clues on the Fed’s near-term trajectory. Given the Fed’s erratic nature this year, there is no telling what she’ll say, so be very careful if you’re placing bets! 3) Kurt Capra on SCTY Today on T3 Live’s Virtual Trading Floor, my colleague Kurt Capra provided the following analysis on controversial solar stock Solar City (SCTY): SolarCity (SCTY) has been showing weakness and an inability to bounce. The daily chart is set up to break down: Look for a move under the bottom of the range sometime next week. P.S. Don’t forget to sign up for our FREE forex trading webinar. Monday’s Trading Calendar US Economics (Time Zone: EDT) 08:30 Chicago Fed Nat Activity Index (Jul): prior 0.16 Global Economics 08:30 CAD Wholesale Sales m/m Earnings Before Open: None of significance After Close: NQ Mobile Inc (NQ)
Continue Reading -->Webinar Replay: The Future of Trading with Rob Smith
In this special webinar, Rob Smith walks through his unique Quant Edge Trading System, including: The Time Frame Continuity Principle Actionable Signals Broadening Formations Want to catch Rob’s next LIVE webinar? Click here.
Continue Reading -->Scott Redler’s Chart Attack: AAPL, FB
Yesterday’s tactical plan for Apple (AAPL) to buy/test near the 8day was a good road map. Now we’ll see if $108.30ish holds and builds an upper floor to digest a nice post earnings move from $102.75 to $110.23. Some of my spreads expire this Friday. September will sit. Facebook (FB) has been digesting/lethargic since they sold the earnings report at highs. Yesterday could be a start as I nibbled at the 21 day which has been support. In order for it to get better, it needs to take out and close above $124.40 but the real area is $126. Positions Disclosure: Scott J. Redler is long AAPL call spreads, FB P.S. Want to get an edge in today’s algo/HFT-driven markets? Click here to learn about Rob Smith’s FREE Quant Edge Webinar
Continue Reading -->Crude Oil Rocks… and 4 Other Thoughts on Today’s Market
Want to get an edge in today’s algo/HFT-driven markets? Click here to learn about Rob Smith’s FREE Quant Edge Webinar 1) The Beast! Crude oil is an absolute beast with 2 key catalysts pushing it: 1) Fed dovishness, which is pushing down the dollar and 2) hopes for an output freeze or cut at the September OPEC meeting. It seems like everyone forgot that OPEC disappointed at the June meeting after a ton of anticipation that a policy change was in the wings. But that’s the nature of momentum. And oh yeah — check out the nice, slow grind up in HYG. That is a good sign for the bulls. 2) Buh-Buh-Buh-Biotech Biotech (IBB) is putting in a nice bounce off the lows this morning and outperforming by a solid margin. As with HYG, this is a good sign for the bulls And it’s an area the bears need to break to get a real downside move. 3) Russell 2000 Same story as HYG/IBB. 4) Zee VIX! Yesterday’s intraday rally in SPX and today’s rally up to break-even is sending the VIX down below 12 again. This is bad news for me since I’m very much long volatility through VIX calls. I admit I’m growing restless. We haven’t had a 1% down day since June 27, which seems crazy. This stretch is even more boring than the April-May snoozefest. 5) Twilio (TWLO) The other day, I listed 3 reasons I would not short Twilio. That post received a lot of attention. The stock has pulled back a bit, but it still looks like a pretty dangerous short. Put option open interest has gone from 9,710 on Friday, August 5 to 34,394 yesterday. Plus, on August, 5, call open interest was almost double the put open interest. And as of yesterday, the put open interest exceeds the call side. The stock is also Hard Borrow, has big short interest, and there is still a massive put skew. Unless the broader markets really break down, I suspect Twilio shorts will get steamrolled.
Continue Reading -->Morning Call Express: Scattered Opportunities
In today’s Morning Call Express, Scott Redler talks about the SPX and how it has held the 21day. He also looks at various sectors like the IBB and XLE. He also looks at a couple individual names.
Continue Reading -->